Greaney AJ, Starr TN, Barnes CO, Weisblum Y, Schmidt F, Caskey M, Gaebler C, Cho A, Agudelo M, Finkin S et al..  2021.  Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.. Nat Commun. 12(1):4196.

Keeffe JR, Van Rompay KKA, Olsen PC, Wang Q, Gazumyan A, Azzopardi SA, Schaefer-Babajew D, Lee YE, Stuart JB, Singapuri A et al..  2018.  A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.. Cell Rep. 25(6):1385-1394.e7.

Mateos M-V, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P et al..  2018.  Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.. N Engl J Med. 378(6):518-528.

Rao TDharma, Fernández-Tejada A, Axelrod A, Rosales N, Yan X, Thapi S, Wang A, Park KJ, Nemieboka B, Xiang J et al..  2017.  Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.. ACS Chem Biol. 12(8):2085-2096.

Ptashkin RN, Pagan C, Yaeger R, Middha S, Shia J, O'Rourke KP, Berger MF, Wang L, Cimera R, Wang J et al..  2017.  Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.. Mol Cancer Res. 15(6):708-713.

Schardt JS, Oubaid JM, Williams SC, Howard JL, Aloimonos CM, Bookstaver ML, Lamichhane TN, Sokic S, Liyasova MS, O'Neill M et al..  2017.  Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells.. Mol Pharm. 14(4):1047-1056.

Hoffman RW, Merrill JT, Alarcón-Riquelme MME, Petri M, Dow ER, Nantz E, Nisenbaum LK, Schroeder KM, Komocsar WJ, Perumal NB et al..  2017.  Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.. Arthritis Rheumatol. 69(3):643-654.

Ivasyk I, Morgenstern PF, Wembacher-Schroeder E, Souweidane MM.  2017.  Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.. J Neurosurg Pediatr. 20(3):256-260.

Mayer CT, Gazumyan A, Kara EE, Gitlin AD, Golijanin J, Viant C, Pai J, Oliveira TY, Wang Q, Escolano A et al..  2017.  The microanatomic segregation of selection by apoptosis in the germinal center.. Science. 358(6360)

Röhrig F, Vorlová S, Hoffmann H, Wartenberg M, Escorcia FE, Keller S, Tenspolde M, Weigand I, Gätzner S, Manova K et al..  2017.  VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.. Oncogene. 36(1):1-12.

Price EW, Carnazza KE, Carlin SD, Cho A, Edwards KJ, Sevak KK, Glaser JM, de Stanchina E, Janjigian YY, Lewis JS.  2017.  Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.. J Nucl Med. 58(9):1386-1394.

Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No D, Gobourne A, Littmann E, Huttenhower C et al..  2016.  Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.. Nat Commun. 7:10391.

Chang AY, Gejman RS, Brea EJ, Oh CY, Mathias MD, Pankov D, Casey E, Dao T, Scheinberg DA.  2016.  Opportunities and challenges for TCR mimic antibodies in cancer therapy.. Expert Opin Biol Ther. 16(8):979-87.

Behling K, Maguire WF, Puebla JCarlos Ló, Sprinkle SR, Ruggiero A, O'Donoghue J, Gutin PH, Scheinberg DA, McDevitt MR.  2016.  Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.. J Nucl Med. 57(10):1576-1582.

Maguire WF, McDevitt MR, Smith-Jones PM, Scheinberg DA.  2014.  Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for α-particle radioimmunotherapy of cancer.. J Nucl Med. 55(9):1492-8.

Wang CQF, Suárez-Fariñas M, Nograles KE, Mimoso CA, Shrom D, Dow ER, Heffernan MP, Hoffman RW, Krueger JG.  2014.  IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood.. J Invest Dermatol. 134(12):2990-2993.

Dubrovsky L, Pankov D, Brea EJoseph, Dao T, Scott A, Yan S, O'Reilly RJ, Liu C, Scheinberg DA.  2014.  A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias.. Blood. 123(21):3296-304.

Fan X, Upadhyaya B, Wu L, Koh C, Santín-Durán M, Pittaluga S, Uzel G, Kleiner D, Williams E, Ma CA et al..  2012.  CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome.. Clin Immunol. 143(2):152-61.

Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, O'Connor OA, Yahalom J, Zelenetz AD.  2005.  R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.. Leuk Lymphoma. 46(4):541-7.

Lappin RI, Rubin LL, Lieberburg IM.  1987.  Generation of subunit-specific antibody probes for Torpedo acetylcholinesterase: cross-species reactivity and use in cell-free translations.. J Neurobiol. 18(1):75-99.